Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Scherzer

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Brain Communications|July 8, 2022
Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairmentPia Kivisäkk, Colin Magdamo, Bianca A Trombetta, et al.
Medrxiv : the Preprint Server for Health Sciences|February 26, 2024
Disease progression strikingly differs in research and real-world Parkinson's populationsBrett K Beaulieu-Jones, Francesca Frau, Sylvie Bozzi, et al.
Biochimica Et Biophysica Acta|May 13, 2010
Reduced creatine kinase as a central and peripheral biomarker in Huntington's diseaseJinho Kim, Daniel J Amante, Jennifer P Moody, et al.
Neurobiology of Disease|October 4, 2005
Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer diseasePu-Ting Xu, Yi-Ju Li, Xue-Jun Qin, et al.
NPJ Parkinson'S Disease|March 14, 2024
Disease progression strikingly differs in research and real-world Parkinson's populationsBrett K Beaulieu-Jones, Francesca Frau, Sylvie Bozzi, et al.
The Lancet. Neurology|July 21, 2023
Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trialNir Giladi, Roy N Alcalay, Gary Cutter, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Genetic screening and metabolomics identify glial adenosine metabolism as a therapeutic target in Parkinson's diseaseMaggie J Sodders, Julian Avila-Pacheco, Ernest C Okorie, et al.
NPJ Parkinson'S Disease|November 23, 2021
Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson's disease enrolled in PPMIYoung Eun Huh, Hyejung Park, Ming Sum Ruby Chiang, et al.
JAMA Network Open|April 21, 2021
Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease ProgressionRoberto A Ortega, Cuiling Wang, Deborah Raymond, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Integrating Long-Read Structural Variant Analysis with single-nucleus RNA-seq to Elucidate Gene Expression Effects in DiseaseKwanho Kim, Zechuan Lin, Sean K Simmons, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Brain Communications|July 8, 2022
Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairmentPia Kivisäkk, Colin Magdamo, Bianca A Trombetta, et al.
Medrxiv : the Preprint Server for Health Sciences|February 26, 2024
Disease progression strikingly differs in research and real-world Parkinson's populationsBrett K Beaulieu-Jones, Francesca Frau, Sylvie Bozzi, et al.
Biochimica Et Biophysica Acta|May 13, 2010
Reduced creatine kinase as a central and peripheral biomarker in Huntington's diseaseJinho Kim, Daniel J Amante, Jennifer P Moody, et al.
Neurobiology of Disease|October 4, 2005
Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer diseasePu-Ting Xu, Yi-Ju Li, Xue-Jun Qin, et al.
NPJ Parkinson'S Disease|March 14, 2024
Disease progression strikingly differs in research and real-world Parkinson's populationsBrett K Beaulieu-Jones, Francesca Frau, Sylvie Bozzi, et al.
The Lancet. Neurology|July 21, 2023
Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trialNir Giladi, Roy N Alcalay, Gary Cutter, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Genetic screening and metabolomics identify glial adenosine metabolism as a therapeutic target in Parkinson's diseaseMaggie J Sodders, Julian Avila-Pacheco, Ernest C Okorie, et al.
NPJ Parkinson'S Disease|November 23, 2021
Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson's disease enrolled in PPMIYoung Eun Huh, Hyejung Park, Ming Sum Ruby Chiang, et al.
JAMA Network Open|April 21, 2021
Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease ProgressionRoberto A Ortega, Cuiling Wang, Deborah Raymond, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Integrating Long-Read Structural Variant Analysis with single-nucleus RNA-seq to Elucidate Gene Expression Effects in DiseaseKwanho Kim, Zechuan Lin, Sean K Simmons, et al.
Pageof 14